HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Massard, G. Articles by Morand, G. Search for Related Content PubMed PubMed Citation Articles by Massard, G. Articles by Morand, G.

The Journal of Thoracic and Cardiovascular Surgery, Vol 106, 218-227, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Bronchogenic cancer associated with head and neck tumors. Survival analysis of 194 patients

G Massard, N Roeslin, GM Jung, P Dumont, JM Wihlm and G Morand
Service de Chirurgie Thoracique, Hospices Civils, Strasbourg, France.

We reviewed a series of 194 lung opacities presumed to be bronchogenic carcinomas occurring either simultaneously with (n = 46) or metachronously to (n = 148) a head and neck cancer. The purpose of the study was to evaluate the operative mortality and morbidity and to assess with a survival analysis whether the lung lesions actually were primary carcinomas or metastases of the head and neck cancer. Operation was contraindicated in 77 patients: 36 for metastatic spread, 5 for small-cell carcinoma, and 35 for respiratory insufficiency. The remaining 118 underwent operation: lobectomy for 82, pneumonectomy for 30, wedge resection for 1, and exploratory thoracotomy for 5. The operative mortality was 5%, and the nonfatal morbidity was 22%. The survival at 5 years for patients who underwent operation for bronchogenic cancer was 19.7% (27.2% for stage I, 19% for stage II, 4.5% for stage IIIA, and 0% for stage IIIB). The survival of these patients was not significantly different with respect to the synchronous or metachronous occurrence or the histologic classification (squamous or non-squamous). We conclude that, despite the poor survival, several of these lung lesions associated with a head and neck cancer were most likely a primary bronchogenic cancer. Surgical management is justified because of the observed postoperative mortality.

This article has been cited by other articles:

				D. L. Schwartz, J. Rajendran, B. Yueh, M. Coltrera, Y. Anzai, K. Krohn, and J. Eary Staging of Head and Neck Squamous Cell Cancer With Extended-Field FDG-PET Arch Otolaryngol Head Neck Surg, November 1, 2003; 129(11): 1173 - 1178. [Abstract] [Full Text] [PDF]

				M. K. Wax, L. L. Myers, E. C. Gabalski, S. Husain, J. M. Gona, and H. Nabi Positron Emission Tomography in the Evaluation of Synchronous Lung Lesions in Patients With Untreated Head and Neck Cancer Arch Otolaryngol Head Neck Surg, June 1, 2002; 128(6): 703 - 707. [Abstract] [Full Text] [PDF]

				T. Mom, M. Filaire, D. Advenier, C. Guichard, A. Naamee, G. Escande, X. Llompart, L. Vallet, J. Gabrillargues, C. Courtalhiac, et al. Concomitant type I thyroplasty and thoracic operations for lung cancer: Preventing respiratory complications associated with vagus or recurrent laryngeal nerve injury J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 642 - 648. [Abstract] [Full Text] [PDF]

				G. Massard, X. Ducrocq, M. Beaufigeau, S. Elia, R. Kessler, J.-F. Herve, and J.-M. Wihlm Lung cancer following previous extrapulmonary malignancy Eur. J. Cardiothorac. Surg., November 1, 2000; 18(5): 524 - 528. [Abstract] [Full Text] [PDF]

				N. Martini, M. S. Bains, M. E. Burt, M. F. Zakowski, P. McCormack, V. W. Rusch, and R. J. Ginsberg Incidence of local recurrence and second primary tumors in resected stage I lung cancer J. Thorac. Cardiovasc. Surg., January 1, 1995; 109(1): 120 - 129. [Abstract] [Full Text]